Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Dapagliflozin
- Therapeutic area
- Endocrine & metabolic
- Drug class
- Antidiabetic medicines
- ATC
- A10BK
- Strength
- 10 mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 107375
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-12 02:58
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Dapwiz (Dapagliflozin) is used for
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Dapagliflozin is right for you and the dose.
- Chronic kidney disease: slow kidney damage and lower the risk of kidney failure and heart problems, in people with or without diabetes
- Heart failure: core medicine for reduced ejection fraction and also used in mildly reduced and preserved ejection fraction
- Type 2 diabetes mellitus: given with metformin as first-line treatment for most adults
About Dapwiz 10 mg tablet
Dapwiz 10 mg tablet contains Dapagliflozin 10 mg. It is registered with DRAP by PHARMEVO (PVT) LTD (registration no. 107375). Its official price is PKR 687.54 for a pack of 10's, about PKR 68.75 per tablet. This price has applied since 4 August 2025. It is sold in 3 pack sizes: 10's, 14's and 7x4's. Dapwiz is also available as 5 mg tablet. 2 other brands of Dapagliflozin 10 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Dapwiz 10 mg pack sizes and prices
Other strengths of Dapwiz
All 2 other brands of Dapagliflozin 10 mg tablet in Pakistan
These 2 brands are alternatives (substitutes) to Dapwiz: each contains Dapagliflozin 10 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Dapxi (Nabiqasim Industries (Pvt) Ltd) at PKR 66.25 per tablet; the highest is Dapatit at PKR 110. All prices are official DRAP prices.
How old is this price? It was fixed on 4 August 2025 and has not changed since — that is 15 months ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Dapwiz, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- PHARMEVO (PVT) LTD., Karachi
- DRAP registration
- 107375
- Phone
- +92 21 34315195-7
- mail@pharmevo.biz
- Website
- https://pharmevo.biz/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (10's). Current price PKR 687.54, effective 4 Aug 2025.
Cite this price history
MedInfoBase. Dapwiz 10 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/dapwiz-10-mg-107375-10s-pharmevo-pvt-ltd-4134/ (accessed 12 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 687.54 | 2025-08-04 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 107375Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.